3
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 309-320 | Published online: 27 Sep 2008

References

  • , 5-Fluorouracil-loaded chitosan microspheres: Preparation and release characteristics
  • Akbuga J., Bergisadi N. J Microencapsulation 1996; 13(2)161–168
  • , A new embolic material. Superabsorbent polymer (SAP) microsphere and its embolic effects
  • Yao J., Hori S., Minamitani K., Hashimoto T., Yoshimura H., Nomura N., Ishida T., Fukuda H., Tomoda K., Nakamura H. Nippon Igaku Hoshasen Gakkai Zasshi 1996; 56(1)19–24
  • , A quantitative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzyme-linked immunosorbent assay
  • Okada N., Fushimi M., Nagata Y., Fukunaga T., Tsutsumi Y., Nakagawa S., Mayumi T. Jpn J Cancer Res 1995; 86(12)1182–1188
  • , A novel method of preparing PLGA microcapsules utilizing methyl ethyl ketone
  • Sah H., Smith M. S., Chern R. T. Pharm Res 1996; 13(3)360–367
  • , Adjuvant therapy for osteosarcoma in dogs: Results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin
  • Kurzman I. D., MacEwen E. G., Rosenthal R. C., Fox L. E., Keller E. T., Helfand S. C., Vail D. M., Dubielzig R. R., Madewell B. R., et al. Clin Cancer Res 1995; 1(12)1595–1601
  • , Advances in targeting treatment with liposomal adriamycin
  • Feng B., Li D. Zhongguo Yaoxue Zazhi 1995; 30(9)518–521
  • , Adverse effects at adjuvant treatment of liver metastases in rat with RSU-1069+microspheres, or liposomal MTP-PE
  • Wang L., Roos G., Stenram U. Anticancer Res 1995; 15(5B)2077–2080
  • , Aggregation of ligand-modified liposomes by specific interactions with proteins. I: Biotinylated liposomes and avidin
  • Lynch N. J., Kilpatrick P. K., Carbonell R. G. Biotechnol Bioeng 1996; 50(2)151–168
  • , Aggregation of ligand-modified liposomes by specific interactions with proteins. II: Biotinylated liposomes and antibiotin antibody
  • Lynch N. J., Kilpatrick P. K., Carbonell R. G. Biotechnol Bioeng 1996; 50(2)169–183
  • , Albumin–heparin microspheres as a drug delivery carrier
  • Bae Y.-H., Kwon G., Cremers H., Kim S.-W., Feijen J. Yakche Hakhoechi 1995; 25: S21–S32, 3, Suppl., Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: Clinical and immunobiological effects
  • Adler A., Schachter J., Barenholz Y., Bar L. K., Klein T., Korytnaya R., Sulkes A., Michowiz R., Cohen Y., Kedar I. Cancer Biother 1995; 10(4)293–306
  • , Animal experiment and clinical trial of hepatic artery chemoembolization with cisplatin microspheres in the treatment of hepatocellular carcinoma
  • Pu Y., Zhao Y., Zhu J., Yi B., Xue W., Qie X., Wang Y., Shi T. Beijing Yike Daxue Xuebao 1995; 27(5)381–383
  • , Animal species dependent liposome clearance
  • Liu D. J Liposome Res 1996; 6(1)77–97
  • , Antibody dependent, complement mediated liver uptake of liposomes containing GM1
  • Liu D., Song Y.-K., Liu F. Pharm Res 1995; 12(11)1775–1780
  • , Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant
  • Sedlik C., Perraut R., Bonnemains B., Leclerc C. Immunobiology (Stuttgart) 1996; 195(1)105–118
  • , Antimicrobial therapy in periodontics
  • Slots J., van Winkelhoff A. J. J Calif Dent Assoc 1993; 21(11)51–56
  • , Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro
  • Korba B. E., Gerin J. L. Antiviral Res 1995; 28(3)225–242
  • , Antisense strategies in the treatment of leukemias
  • Calabretta B., Skorski T., Ratajczak M. Z., Gewirtz A. M. Semin Oncol 1996; 23(1)78–87
  • , Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma
  • Tokudome Y., Oku N., Doi K., Namba Y., Okada S. Biochim Biophys Acta 1996; 1279(1)70–74
  • , Antitumor effect of liposome-entrapped carboplatin administered via the portal vein in rats
  • Terada J., Mizuno I., Manabe T., Yotsuyanagi T., Mohri N. Drug Delivery Syst 1996; 11(1)21–25
  • , Antitumor effect of mitoxantrone-containing liposomes
  • Law S. L., Ho C. K., Jang T. F., Chang P., Lin F. M. Int J Pharm 1996; 128(1,2)139–143
  • , Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus
  • Kim S. G., Hatta T., Tsukahara S., Nakashima H., Yamamoto N., Shoji Y., Takai K., Takaku H. Bioorg Med Chem 1995; 3(1)49–54
  • , Applicability of monoclonal antibody FAB fragments as a carrier of neocarzinostatin in targeting chemotherapy
  • Otsuji E., Yamaguchi T., Tsuruta H., Yata Y., Nishi H., Okamoto K., Taniguchi K., Kato M., Kotani T., Kitamura K., Takahashi T. J Surg Oncol 1996; 61(2)149–154
  • , Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy
  • Mizuguchi H., Nakanishi M., Nakanishi T., Nakagawa T., Nakagawa S., Mayumi T. Br J Cancer 1996; 73(4)472–476
  • , Application of 99mTc labeling for fast comparative screening of preformed liposomes in vivo
  • Panagi Z., Sawas-Dimopoulou C., Avgoustakis K., Ithakissios D. S. Drug Dev Ind Pharm 1996; 22(3)217–224
  • , Application of antibody and fluorophore-derivatized liposomes to heterogeneous immunoassays for D-dimer
  • Singh A. K., Kilpatrick P. K., Carbonell R. G. Biotechnol Prog 1996; 12(2)272–280
  • , Basic experiment of BBB permeability of cisplatin encapsulated in liposome by means of in vitro BBR model with bovine brain microvessel endothelial cells
  • Anda T., Yamashita H., Fujita H., Tokunaga Y., Shibata S. Drug Delivery Syst 1995; 10(6)425–430
  • , Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: Influence of PEG content and its molecular weight
  • Vertut D. A., Ishiwata H., Miyajima K. Biochim Biophys Acta 1996; 1278(1)19–28
  • , Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate
  • Narayani R., Rao K. P. Int J Pharm 1996; 18(1,2)261–268
  • , Can the microsphere model be applied to cerebral blood flow measurement using N-isopropyl-p-(123I) iodo amphetamine with SPET regardless of washout from brain tissue?
  • Ohkubo M., Odano I., Takahashi N., Sakai K. Nucl Med Commun 1995; 16(12)1026–1033
  • , Cardioprotection by liposome-conjugated sialyl Lewis-oligosaccharide in myocardial ischemia and reperfusion injury
  • Murohara T., Margiotta J., Phillips L. M., Paulson J. C., DeFrees S., Zalipsky S., Guo L. S. S., Lefer A. M. Cardiovasc Res 1995; 30(6)965–974
  • , Cells involved in removing liposomes from the blood circulation: Why are they so special?
  • Scherphof G. L., Crommelin D. J. A. J Liposome Res 1996; 6(1)19–32
  • , Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells
  • Rosenblum M. G., Cheung L., Kim S. K., Mujoo K., Donato N. J., Murray J. L. Cancer Immunol Immunother 1996; 42(2)115–121
  • , Cellulose acetate trimellitate ethyl cellulose blends for non-steroidal anti-inflammatory drug (NSAID) microspheres
  • Giunchedi P., Torre M. L., Maggi L., Conti B., Conte U. J Microencapsulation 1996; 13(1)89–98
  • , Cerebral blood flow measured with intracerebral laser–Dopplerflow probes and radioactive microspheres
  • Kirkeby O. J., Rise I. R., Nordsletten L., Skjeldal S., Hall C., Risoe C. J Appl Physiol 1995; 79(5)1479–1486
  • , Characteristics and drug release profiles of multilamellar vesicle (MLV) and microemulsified liposome (MEL) containing 5-fluorouracil and its derivatives
  • Jee U.-K., Park M.-S., Lee G.-W., Lyu Y.-G. Yakehe Hakhoechi 1995; 25(3)249–264
  • , Characterization of enzyme immobilization in liposomes prepared from proliposomes
  • Dufour P., Vuillemard J.-C., Laloy E., Simard R. E. J Microencapsulation 1996; 13(2)185–194
  • , Chitosan microspheres of diclofenac sodium: I. Application of factorial design and evaluation of release kinetics
  • Acikgoez M., Kas H. S., Orman M., Hincal A. A. J Microencapsulation 1996; 13(2)141–159
  • , Cisplatin incorporated in microspheres, the development and fundamental studies for its clinical application
  • Osaki K. Kyoto-furitsu Ika Daigaku Zasshi 1995; 104(11)1225–1240
  • , Clearing of psoriasis by a novel immunosuppressive macrolide
  • Rappersberger K., Meingassner J. G., Fialla R., Fodinger D., Sterniczky B., Rauch S., Putz E., Stutz A., Wolff K. J Invest Dermatol 1996; 106(4)701–710
  • , Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells
  • Baghdiguian S., Boudier J. A., Boudier J. L., Fantini J. Cancer Lett 1996; 101(2)179–184
  • , Coating liposomes with collagen (Mr 50,000) increases uptake into liver
  • Fonseca M. J., Alsina M. A., Reig F. Biochim Biophys Acta 1996; 1279(2)259–265
  • , Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells
  • Press O. W., Shan D., Howell C. J., Eary J., Appelbaum F. R., Matthews D., King D. J., Haines A. M., Hamann P., Hinman L., Shochat D., Bernstein I. D. Cancer Res 1996; 56(9)2123–2129
  • , Comparison of pharmacokinetics and tissue distribution between cytarabine and cytarabine liposome in rats and dogs
  • Liu B., Xia D. Zhongguo Yaoxue Zazhi 1995; 30(10)615–617
  • , Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa
  • Omri A., Ravaorinoro M. Chemotherapy (Basel) 1996; 42(3)170–176
  • , Comparison of volume output from two different continuous nebulizer systems
  • Reisner C., Lee J., Kotch A., Dworkin G. Ann Allergy Asthma Immunol 1996; 76(2)209–213
  • , Computer-aided design of bioerodible devices with optimal release characteristics: A cellular automata approach
  • Zygourakis K., Markenscoff P. A. Biomaterials 1996; 17(2)125–135
  • , Continuous spinal analgesia in home care of oncologic pain
  • Ricci V., Dalpane A., Lolli E. Minerva Med 1995; 86(10)409–414
  • , Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid)
  • Andreopoulos A. G. J Biomater Appl 1995; 10(2)163–170
  • , Cytoplasmic chaperones determine the targeting pathway of precursor proteins to mitochondria
  • Komiya T., Sakaguchi M., Mihara K. EMBO J 1996; 15(2)399–407
  • , Delivery of macromolecules into cytosol using liposomes containing hemolysin from listeria monocytogenes
  • Lee K.-D., Oh Y.-K., Portnoy D. A., Swanson J. A. J Biol Chem 1996; 271(13)7249–7252
  • , Delivery of molecular medicine to solid tumors
  • Jain R. K. Science 1996; 271(5252)1079–1080
  • , Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
  • Tat A., Golan H., Grauer N., Aviram M., Albin D., Quastel M. R. J Pediatr 1996; 128(4)479–484
  • , Derivation and cross-validation of pharmacokinetic parameters for computer-controlled infusion of lidocaine in pain therapy
  • Schnider T. W., Gaeta R., Brose W., Minto C. F., Gregg K. M., Shafer S. L. Anesthesiology 1996; 84(5)1043–1050
  • , Determination of the thickness of the fixed aqueous layer around polyethylene glycol-coated liposomes
  • Shimada K., Miyagishima A., Sadzuka Y., Nozawa Y., Mochizuki Y., Ohshima H., Hirota S. J Drug Targeting 1995; 3(4)283–289
  • , Dexamethasone–cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans
  • Kristinsson J. K., Fridriksdottir H., Thorisdottir S., Sigurdardottir A. M., Stefansson E., Loftsson T. Invest Ophthalmol Vis Sci 1996; 37(6)1199–1203
  • , Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin
  • Wasan K. M., Morton R. E. Pharm Res 1996; 13(3)462–468
  • , Differential biodistribution of encapsulated and surface-linked liposomal antigens
  • Therien H. M., Shahum E. Biochim Biophys Acta 1996; 1280(1)91–97
  • , Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis
  • Williams A. S., Camilleri J. P., Amos N., Williams B. D. Clin Exp Immunol 1995; 102(3)560–565
  • , Dihydroxyacetone in microspheres. A technical approach to overcome problems in the use of DHA in cosmetic sun products
  • Garces J., Bonilla A., Corma C., Parente A., Garcia-Anton J. M. Cosmet News 1995; 18(105)420–422
  • , DNA/liposome as drug delivery system in the gene therapy
  • Mizuno M., Yoshida J. Drug Delivery Syst 1995; 10(6)399–403
  • , Double emulsion microencapsulation of proteins as model antigens using polylactide polymers. Effect of emulsifier on the microsphere characteristics and release kinetics
  • Conway B. R., Alpar H. O. Eur J Pharm Biopharm, 42(1)42–48
  • , Double long-chain amidine liposome-mediated self replicating RNA transfection
  • El-Ouahabi A., Pector V., Fuks R., Van denbranden M., Ruysschaert J. M. FEBS Lett 1996; 380(1,2)108–112
  • , Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma
  • Northfelt D. W., Martin F. J., Working P., Volberding P. A., Russell J., Newman M., Amantea M. A., Kaplan L. D. J Clin Pharmacol 1996; 36(1)55–63
  • , Doxorubicin in sterically stabilized liposomes
  • Lasic D. D. Nature (London) 1996; 380(6574)561–562
  • , Drug delivery system for metastatic mediastinal lymph nodes using ADM-encapsulated liposomes through a bronchofiberscope—an experimental study
  • Wei B.-R., Takahashi H. Tokyo Ika Daigaku Zasshi 1995; 53(6)815–824
  • , Effect of donor strains and age of the recipient in the use of microencapsulated hepatocytes to control hyperbilirubinemia in the Gunn rat
  • Bruni S., Chang T.-M. Mt J Artif Organs 1995; 18(6)332–339
  • , Effect of aging on arteriolar dilatation induced by prostaglandin El incorporated in lipid microspheres
  • Hirose M., Chun T.-Y., Miyazaki M. J Cardiovasc Pharmacol 1996; 27(5)749–751
  • , Effect of microcapsule size and polyisobutylene concentration on the release of theophylline from ethylcellulose microcapsules
  • Sa B., Bandyopadhyay A. K., Gupta B. K. J Microencapsulation 1996; 13(2)207–218
  • , Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery
  • Jeyanthi R., Thanoo B. C., Metha R. C., DeLuca P. P. J Controlled Release 1996; 38(2,3)235–244
  • , Effect of a single infusion of recombinant human proapolipoprotein A-I liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol
  • Carlson L. A. Nutr, Metab Cardiovasc Dis 1996; 5(2)85–91
  • , Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography
  • Oku N., Tokudome Y., Namba Y., Saito N., Endo M., Hasegawa Y., Kawai M., Tsukada H., Okada S. Biochim Biophys Acta 1996; 1280(1)149–154
  • , Effectiveness of liposomal forms of cytostatics
  • Dramov A. L., Dudnichenko A. S., Mezin I. A., Menzeleev R. F., Krasnopolskii Y. M., Shvets V. I. Byull Eksp Biol Med 1996; 121(1)85–88
  • , Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes
  • Hara T., Kuwasawa H., Aramaki Y., Takada S., Koike K., Ishidate K., Kato H., Tsuchiya S. Biochim Biophys Acta 1996; 1278(1)51–58
  • , Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I
  • Trafny E. A., Stcepinska M., Antos M., Grzybowski J. Antimicrob Agents Chemother 1995; 39(12)2645–2649
  • , Effects of glucose and its oligomers on the stability of freeze-dried liposomes
  • Suzuki T., Komatsu H., Miyajima K. Biochim Biophys Acta 1996; 1278(2)176–182
  • , Effects of orally administered liposomes with soybean-derived sterols and their glucosides on rat body weight
  • Maitani Y., Hazama M., Tojo H., Qi X.-R., Nagai T. Biol Pharm Bull 1995; 18(11)1551–1555
  • , Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
  • Friend D. S., Papahadjopoulos D., Debs R. J. Biochim Biophys Acta 1996; 1278(1)41–50
  • , Engineering liposomes for drug delivery: Progress and problems
  • Gregoriadis G. Trends Biotechnol 1995; 13(12)527–537
  • , Enhanced therapeutic effect of cytidine-5′-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model
  • Fresta M., Wehrli E., Puglisi G. Pharm Res 1995; 12(11)1769–1774
  • , Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus
  • Raja W. R., Webber J., Naftilan J., Chapman G. D., Naftilan A. J. Gene Ther 1995; 2(8)521–530
  • , Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection
  • Beaulac C., Clement-Major S., Hawari J., Lagace J. Antimicrob Agents Chemother 1996; 40(3)665–669
  • , Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer
  • Egilmez N. K., Iwanuma Y., Bankert R. B. Biochem Biophys Res Commun 1996; 221(1)169–173
  • , Evaluation of a delivery system providing long-term release of cyclosporine
  • Pearson P. A., Jaffe G. J., Martin D. F., Cordahi G. J., Grossniklaus H., Schmeisser E. T., Ashton P. Arch Ophthalmol 1996; 114(3)311–317
  • , Fate of DNA targeted to hepatocytes by asialoglycoprotein polylysine conjugates
  • Wu G.-W., Chowdhury J. R., Bommineni V. R., Basu S. K., Wu C.-H., Chowdhury N. R. Proc Assoc Am Physicians 1995; 107(2)211–217
  • , Fatty acyl-Co A: Sphingosine acyltransferase in bovine brain mitochondria: Its solubilization and reconstitution onto the membrane lipid liposomes
  • Shimeno H., Soeda S., Yasukouchi M., Okamura N., Nagamatsu A. Biol Pharm Bull 1995; 18(10)1335–1339
  • , Feasibility of topical liposome drugs produced on an industrial scale
  • Naeff R. Adv Drug Delivery Rev 1996; 18(3)343–347
  • , Fluorescence probe studies of the interactions of 1-alkyl-2-pyrrolidones with stratum corneum lipid liposomes
  • Yoneto K., Li S. K., Higuchi W. I., Jiskoot W., Herron J. N. J Pharm Sci 1996; 85(5)511–117
  • , Folate-targeted, anionic liposome-entrapped polylysinecondensed DNA for tumor cell-specific gene transfer
  • Lee R. J., Huang L. J Biol Chem 1996; 271(14)8481–8487
  • , Formation and characterization of liposomes from lipid/proteic material extracted from pig stratum corneum
  • Lopez O., de La Maza A., Coderch L., Parra J. L. J Am Oil Chem Soc 1996; 73(4)443–448
  • , Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres
  • Owusu A. G., Rogers J. A. J Microencapsulation 1996; 13(2)195–205
  • , Formulation effect on the dermal bioavailability of isothiazolone biocide
  • Jayjock M. A., Hazelton G. A., Lewis P. G., Wooder M. F. Food Chem Toxicol 1996; 34(3)277–282
  • , Formulation of BCNU-loaded microspheres: Influence of drug stability and solubility on the design of the microencapsulation procedure
  • Tones A. I., Boisdron-Celle M., Benoit J. P. J Microencapsulation 1996; 13(1)41–51
  • , Formulation optimization of novel multicomponent photoprotective liposomes by using response surface methodology
  • Loukas Y. L. Analyst (Cambridge, UK) 1996; 121(3)279–284
  • , Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis
  • Khalil R. M., Murad F. E., Yehia S. A., El-Ridy M. S., Salama H. A. Pharmazie 1996; 51(3)182–184
  • , Free amino group content of serum albumin microcapsules. III. A study at low pH values
  • Andry M. C., Edwards-Levy F., Levy M. C. Int J Pharm 1996; 128(1,2)197–202
  • , Gamma-irradiation of liposomes composed of saturated phospholipids. Effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes
  • Zuidam N. J., Versluis C., Vernooy E. A. A. M., Crommelin D. J. A. Biochim Biophys Acta 1996; 1280(1)135–148
  • , Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes
  • Zuidam N. J., Lee S. S., Crommelin D. J. Pharm Res 1995; 12(11)1761–1768
  • , Ganciclovir intraocular implant. A clinicopathologic study
  • Charles N. C., Steiner G. C. Ophthalmology 1996; 103(3)416–421
  • , GDNF slows loss of motoneurons but not axonal degeneration or premature death of PMN/PMN mice
  • Sagot Y., Tan S. A., Hammang J. P., Aebischer P., Kato A. C. J Neurosci 1996; 16(7)2335–2341
  • , Gelatin microspheres in oil in water multiple emulsion of pingyangmycin
  • Li H., Wei S., Lu W. Zhongguo Yaoxue Zazhi 1995; 30(10)600–603
  • , Gene replacement strategies for cancer
  • Roth J. A. Isr J Med Sci 1996; 32(2)89–94
  • , Gene transfer to the retina of rat by liposome eye drops
  • Matsuo T., Masuda I., Yasuda T., Matsuo N. Biochem Biophys Res Commun 1996; 219(3)947–950
  • , Generation and analysis of liposome aerosols
  • Ho J. Drug Targeting Delivery 1995; 6: 199–208
  • , Giant liposomes as potential vesicles for live or attenuated microbial vaccines
  • Gursel I., Antimisiaris S., Jayasekera P., Gregoriadis G. Drug Targeting Delivery 1995; 6: 35–50
  • Handbook of nonmedical applications of liposomes. Theory and basic sciences, D. D. Lasic, B. Yechezkel. CRC, Boca Raton, FL 1996; volume I: 331
  • Handbook of nonmedical applications of liposomes. Models for biological phenomena, D. D. Lasic, B. Yechezkel. CRC, Boca Raton, FL 1996; volume II: 379
  • Handbook of nonmedical applications of liposomes. Design to microreactors, D. D. Lasic, B. Yechezkel. CRC, Boca Raton, FL 1996; volume III: 358
  • Handbook of nonmedical applications of liposomes. Gene delivery and diagnostics to ecology, D. D. Lasic, B. Yechezkel. CRC, Boca Raton, FL 1996; volume IV: 328
  • , Heparin delivery at the site of angioplasty with a novel drug delivery sleeve
  • Kaplan A. V., Vandormael M., Hofmann M., Weil H. J., Storger H., Krajcar M., Gallant P., Simpson J. B., Reifart N. Am J Cardiol 1996; 77(4)307–310
  • , Heparin protection against Fe2+- and Cu2+-mediated oxidation of liposomes
  • Albertini R., Rindi S., Passi A., Pallavicini G., De Luca G. FEBS Lett 1996; 383(3)155–158
  • , Hepatic arterial embolization with cisplatin–chitosanmicrospheres in dogs
  • Wang Y.-M., Shi T.-S., Pu Y.-L., Zhu J.-G., Zhao Y.-L. Yaoxue Xuebao 1995; 30(12)891–895
  • , Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain
  • Miyoshi Y., Date I., Ohmoto T., Iwata H. Exp Neurol, 138(1)169–175
  • , How do polymers prolong circulation time of liposomes?
  • Torchilin V. P. J Liposome Res 1996; 6(1)99–116
  • , Hypericin: A new laser phototargeting agent for human cancer cells
  • Van derWerf Q. M., Saxton R. E., Chang A., Horton D., Paiva M. B., Anderson J., Foote C., Soudant J., Mathey A., Castro D. J. Laryngoscope 1996; 106(4)479–483
  • , Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease
  • Jacobson B. S., Stolz D. B., Schnitzer J. E. Nat Med 1996; 2(4)482–484
  • , Immobilized chymotrypsin on reversibly precipitable polymerized liposome
  • Sun Y., Jin X.-H., Dong X.-Y., Yu K., Zhou X.-Z. Appl Biochem Biotechnol 1996; 56(3)331–339
  • , Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation
  • Alving C. R., Swartz G. M., Jr, Wassef N. M., Ribas J. L., Herderick E. E., Virmani R., Kolodgie F. D., Matyas G. R., Cornhill J. F. J Lab Clin Med 1996; 127(1)40–49
  • , Immunological consequences of nasal drug delivery in dextran microspheres and ethyl(hydroxyethyl) cellulose in rats
  • Pereswetoff-Morath L., Edman P. Int J Pharm 1996; 128(1,2)23–28
  • , Improved absorption of cyclosporine for microemulsion in a pediatric liver transplant recipient with cystic fibrosis
  • Pescovitz M. D., Puente J. G., Jindal R. M., Fitzgerald J., Chong S.-K., Milgrom M. L., Leapman S. B., Filo R. S. Transplantation 1996; 61(2)331–333
  • , In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine
  • Tuncel T., Bergisadi N., Akin L., Otuk G., Kuscu I. Pharmazie 1996; 51(3)168–171
  • , In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-γ and muramyl tripeptide
  • Goldbach P., Dumont S., Kessler R., Poindron P., Stamm A. Am J Physiol 1996; 270(3, Pt. 1)L429–L434
  • , In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes
  • Fortunati E., Bout A., Zanta M. A., Valerio D., Scarpa M. Biochim Biophys Acta 1996; 1306(1)55–62
  • , In vitro characteristics of nicotine microspheres for transnasal delivery
  • Cornaz A. L., De Ascentis A., Colombo P., Buri P. Int J Pharm 1996; 129(1,2)175–183
  • , In vivo antitumor activity of cis-bis-neodecanoato-trans-R, R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes
  • Mori A., Wu S.-P., Han I., Khokhar A. R., Perez-Soler R., Huang L. Cancer Chemother Pharmacol 1996; 37(5)435–444
  • , In vivo behavior of liposomes modified with a novel galactosyllipid derivative
  • Murahashi N., Sasaki A. Biol Pharm Bull 1996; 19(3)418–423
  • , In vitro studies with liposomal cryptolepine
  • Singh M., Singh M. P., Ablordeppey S. Drug Dev Ind Pharm 1996; 22(4)377–381
  • , Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa
  • Omri A., Ravaoarinoro M., Poisson M. J Antimicrob Chemother 1995; 36(4)631–639
  • , Influence of phospholipid chain length on verotoxin/ globotriaosyl ceramide binding in model membranes: Comparison of a supported bilayer film and liposomes
  • Arab S., Lingwood C. A. Glycoconjugate J 1996; 13(2)159–166
  • , Influenza virus–liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane
  • Shangguan T., Alford D., Bentz J. Biochemistry 1996; 35(15)4956–4965
  • , Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA–liposome complexes
  • Sugaya S., Fujita K., Kikuchi A., Ueda H., Takakuwa K., Kodama S., Tanaka K. Hum Gene Ther 1996; 7(2)223–230
  • , Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles
  • Heller–Harrison R. A., Morin M., Guilherme A., Czech M. P. J Biol Chem 1996; 271(17)10200–10204
  • , Interaction of liposomes with human skin: The role of the stratum corneum
  • Schaller M., Korting H. C. Adv Drug Delivery Rev 1996; 18(3)303–309
  • , Intramuscular fate and local effects of liposomes as carriers for drugs and vaccines
  • Richards R. L., Hailey J. R., Egan J. E., Gordon D. M., Johnson A. J., Alving C. R., Wassef N. M. Drug Targeting Delivery 1995; 6: 167–178
  • , Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth
  • Mizuguchi H., Nakanishi T., Nakanishi M., Nakagawa T., Nakagawa S., Mayumi T. Cancer Lett (Shannon, Ireland) 1996; 100(1,2)63–69
  • , Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3
  • Sahu A., Pangburn M. K. Biochem Pharmacol 1996; 22(51)6, 797–804
  • , Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells
  • Paiva M. B., Saxton R. E., Letts G., Chung P. S., Soudant J., Vanderwerf Q., Castro D. J. Laryngoscope 1996; 106(3, Pt. 1)257–262
  • , Liposomal methylprednisolone in rats: Dose-proportionality and chronic-dose pharmacokinetics/pharmacodynamics
  • Mishina E. V., Jusko W. J. Pharm Res 1996; 13(1)141–145
  • , Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: Bactericidal efficacy
  • Soltes S., Mustard R. A., Shek P. N., Florio E., Bohnen J. M., Mittelman M. W. Shock 1995; 4(5)373–378
  • , Liposomal ATP protects the liver from injury during shock
  • Konno H., Matin A. F. M., Maruo Y., Nakamura S., Baba S. Eur Surg Res 1996; 28(2)140–145; 96
  • , Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys
  • Kramer M., Miller J. W., Michaud N., Moulton Hasan R. S. T., Flotte T. J., Gragoudas E. S. Ophthalmology 1996; 103(3)427–438
  • , Liposomal chemotherapy for AIDS-related Kaposi's sarcoma
  • Harrison M., Harrington K. J., Stewart J. S. W. Expert Opin Invest Drugs 1995; 4(12)1197–1203
  • , Liposomal DNA delivery
  • Son K., Huang L. Drug Targeting Delivery 1995; 4: 321–336
  • , Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan
  • Subramanian D., Muller M. T. Oncol Res 1995; 7(9)461–469
  • , Liposomal vaccines
  • Green S., Fortier A., Dijkstra J., Madsen J., Swartz G., Einck L., Gubish E., Nacy C. Adv Exp Med Biol 1996; 383: 83–92, Immunobiology of Proteins and Peptides VIII
  • , Liposome clearance: How much do we know about the biological factors that control the process?
  • Liu D. J Liposome Res 1996; 6(1)1–17
  • , Liposome longevity and stability in circulation: Effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines
  • Gabizon A., Chemla M., Tzemach D., Horowitz A. T., Goren D. J Drug Targeting 1996; 3(5)391–398
  • , Liposome mediated delivery of water soluble antibiotics to the larvae of aquatic animals
  • Touraki M., Rigas P., Kastritsis C. Aquaculture 1995; 136(1,2)1–10
  • , Liposome preparation methods
  • Riaz M. Pak J Pharm Sci 1996; 9(1)65–77
  • , Liposome-associated antioxidants for pulmonary applications
  • Suntres Z. E., Shek P. N. Drug Targeting Delivery 1995; 6: 179–198
  • , Liposome–blood protein interactions in relation to liposome clearance
  • Semple S. C., Chonn A. J Liposome Res 1996; 6(1)33–60
  • , Liposome-coated local anesthetics and opioids: A pharmacotechnicological advance in progress
  • dos Prazeres Barbalho-Simonetti M., Pavan de Andrade M. Rev Bras Anestesiol 1996; 46(1)35–42
  • , Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylme-thoxypropyl) cytosine for long-acting therapy of viral retinitis
  • Kuppermann B. D., Assil K. K., Vuong C., Besen G., Wiley C. A., De Clereq E., Bergeron L. G., Connor J. D., Pursley M., et al. J Infect Dis 1996; 173(1)18–23
  • , Liposome-encapsulated ciprofloxacin for the prevention and treatment of infectious diseases caused by intracellular pathogens
  • Wong J.-P., Cherwonogrodzky J. W., Di Ninno V. L., De La Cruz R., Saravolac E. G. Drug Targeting Delivery 1995; 6: 105–120
  • , Liposome-mediated immune response: Cellular requirements and immunomodulation by bifunctional liposomes
  • Shek P. N., Sabiston B. H. Drug Targeting Delivery 1995; 6: 19–34
  • , Liposome-mediated BDNF cDNA transfer in intact and injured rat brain
  • Iwamoto Y., Yang K., Clifton G. L., Hayes R. L. NeuroReport 1996; 7(2)609–612
  • , Liposome-mediated gene transfer
  • Yanagihara I., Kaneda Y., Inui K., Okada S. Mol Cell Biol Hum Dis 1995; 5: 64–82, Molecular and Cell Biology of Human Gene Therapeutics
  • , Liposomes as immunological adjuvants for protein and peptide vaccines
  • Gregoriadis G. Drug Targeting Delivery 1995; 6: 1–18
  • Liposomes in biomedical applications. Proceedings of the Defense Research Liposome Workshop held in Toronto Ontario. Canada October, 1993; 13–14
  • Drug Targeting Delivery. Liposomes—an industrial view, P. N. Shek. Harwood, LausanneSwitzerland 1995; 6: 280
  • Lasic D. Chem Ind (London) 1996; 6: 210–214
  • , Liposomes and antiviral mucosal immunity
  • De Haan A., Wilschut J. Drug Targeting Delivery 1995; 6: 69–83
  • , Liposomes in ocular drug delivery
  • Ozer A. Y. FABAD Farm Bilimler Derg 1995; 20(4)173–180
  • , Liposomes in the agro/food industry
  • Arnaud J.-P. Agro Food Ind Hi Tech 1995; 6(5)30–36
  • , Liposomes prepared from inverse micelles
  • Lu Z., Wu Y., Zhang B. Gaodeng Xuexiao Huaxue Xuebao 1995; 16: 116–119, 11, Suppl.
  • , Liposomes: Carrier systems in food products
  • Arnaud J.-P. Int Food Ingredients 1995; 5: 29–32
  • , Location of ubiquinone homologs in liposome membranes studied by fluorescence anisotropy of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene
  • Jemiola R. M., Kruk J., Skowronek M., Strzalka K. Chem Phys Lipids 1996; 79(1)55–63
  • , Long-term stability of liposomes containing both tissue-type plasminogen activator and glu-plasminogen
  • Heeremans J. L. M., Mijnheer F. W., Gerritsen H. R., Prevost R., Kluft C., Crommelin D. J. A. Int J Pharm 1996; 129(1,2)191–202
  • , Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronatecontaining liposomes
  • Kinne R. W., Schmidt–Weber C. B., Hoppe R., Buchner E., Palombo K. E., Nuernberg E., Emmrich F. Arthritis Rheum 1995; 38(12)1777–1790
  • , Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtiter plates in an ELISA
  • Laakel M., Bouchard M., Lagace J. J Immunol Methods 1996; 190(2)267–273
  • , Mechanism of anti-HIV activity of negatively charged albumins: Biomolecular interaction with the HIV-1 envelope protein gp120
  • Kuipers M. E., Huisman J. G., Swart P. J., De Bethune M. P., Pauwels R., Schuitemaker H., De Clercq E., Meijer D. K. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11(5)419–429
  • , Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
  • Xu Y., Szoka F. C., Jr. Biochemistry 1996; 35(18)5616–5623
  • Microencapsulated permethrin sprays for control of Southern cattle tick. Boophilus microplus (Canestrini) (Acari: Ixodidae), infesting Holstein dairy heifers on Saint Croix. U.S. Virgin Islands
  • Despins J. L., Hunter J. S., III, Davey R. B., George J. E. J Agric Univ P R 1995; 79(3-4)93–98
  • , Microencapsulation of ketoprofen using w/o/w complex emulsion technique
  • El-Gibaly I., Safwat S. M., Ahmed M. O. J Microencapsulation 1996; 13(1)67–87
  • , Microencapsulation of antitumor, antibiotic and thrombolytic drugs in microgravity
  • Morrison D. R., Mosier B., Cassanto J. NASA Conf Publ 3249 1994; 1: 117–126, Technology 2003
  • , Microencapsulation of chloroquine diphosphate by Eudragit RS100
  • Ndesendo V. M. K., Meixner W., Korsatko W., Wabnegg B. J Microencapsulation 1996; 13(1)1–8
  • , Microencapsulation of drugs by solvent evaporation process
  • Goto S., Uchida T. Pharm Tech Jpn 1996; 12(3)393–404
  • , Mock drug delivery to the proximal aorta during cardiopulmonary resuscitation: Central versus peripheral intravenous infusion with varying flush volumes
  • Gaddis G. M., Dolister M., Gaddis M. L. Acad Emerg Med 1995; 2(12)1027–1033
  • , Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): Effects on hematopoiesis and serum IL-6 levels
  • Rollwagen F. M., Gafney W. C., Pacheco N. D., Davis T. A., Hickey T. M., Nielsen T. B., Rudolph A. S. Exp Hematol 1996; 24(3)429–436
  • , New thioureas and related substances intended for melanoma targeting
  • Mars U., Larsson B. S. Pigment Cell Res 1995; 8(4)194–201
  • , Non-phospholipid fusogenic liposomes
  • El-Baraka M., Pecheur E. I., Wallach D. F. H., Philippot J. R. Biochim Biophys Acta 1996; 1280(1)107–114
  • , Normalization of diabetes by xenotransplantation of cryopreserved microencapsulated pancreatic islets. Application of a new strategy in islet banking
  • Inaba K., Zhou D., Yang B., Vacek I., Sun A.-M. Transplantation 1996; 61(2)175–179
  • , Oligonucleotide targeting to alveolar macrophages by man-nose receptor-mediated endocytosis
  • Liang W.-W., Shi X., Deshpande D., Malanga C. J., Rojanasakul Y. Biochim Biophys Acta 1996; 1279(2)227–234
  • , Optimal radiolabeled liposomes for tumor imaging
  • Ogihara U. I., Sasaki T., Kojima S., Nishigori H. J Nucl Med 1996; 37(2)326–332
  • , Oral administration of recombinant human erythropoietin in liposomes in rats: Influence of lipid composition and size of liposomes on bioavailability
  • Maitani Y., Hazama M., Tojo Y., Shimoda N., Nagai T. J Pharm Sci 1996; 85(4)440–445
  • , Oral antitumor activity in murine L1210 leukemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-β-D-arabinofuranosylcytosine
  • Schwendener R. A., Horber D. H., Odermatt B., Schott H. J Cancer Res Clin Oncol 1996; 122(2)102–108
  • , Oral peptide delivery: Improving the systemic availability of small peptides and enkephalin analogs
  • Lee H. J., Amidon G. L. NIDA Res Monogr 1995; 154: 86–106
  • , Organ targeting in vivo using phage display peptide libraries
  • Pasqualini R., Ruoslahti E. Nature 1996; 380(6572)364–366
  • , Ovalbumin–liposome conjugate induces IgG but not IgE antibody production
  • Naito S., Horino A., Nakayama M., Nakano Y., Nagai T., Mizuguchi J., Komuro K., Uchida T. Int Arch Allergy Immunol 1996; 109(3)223–228
  • , Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants
  • Hewitt C. W., Black K. S. Transplant Proc 1996; 28(2)922–923
  • , Passive and facilitative transport of nucleobases, nucleosides, and oligonucleotides—application to antiviral and other therapies
  • Brewster M. E., Bodor N. NIDA Res Monogr 1995; 154: 61–85
  • , Penetration of intravesical doxorubicin in human bladders.
  • Wientjes M. G., Badalament R. A., Au J. L. Cancer Chemother Pharmacol 1996; 37(6)539–546
  • Peptide attachment to extremities of liposomal surface grafted PEG chains: Preparation of the long-circulating form of laminin pentapeptide. YIGSR
  • Zalipsky S., Puntambekar B., Boulikas P., Engbers C. M., Woodle M. C. Bioconjug Chem 1995; 6(6)705–708
  • , Pesticide and model drug release from carboxymethylcellulose microspheres.
  • Darari R., Hasirci V. J Microencapsulation 1996; 13(1)9–24
  • , Pharmacodynamics of a liposomal preparation for local anaesthesia.
  • Peters H., Moll F. Arzneimittelforschung 1995; 45(12)1253–1256
  • , Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer (see comments)
  • Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C. C., Dantis L., Sklarin N. T., Seidman A. D., Hudis C. A., Moore J., Rosen P. P., Twaddell T., Henderson I. C., Norton L. J Clin Oncol 1996; 14(3)737–744
  • , Phase separation in microcapsule membranes composed of soybean lecithin, cholesterol, stearic acid, and polyvinylpyrrolidone.
  • Jono K., Ichikawa H., Fukumori Y., Kanamori R., Tsutsumi Y., Murata K., Morimoto A., Nakamura K. Chem Pharm Bull 1996; 44(2)392–398
  • , Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
  • Young L. H. Y., Howard M. A., Hu L.-K., Kim R. Y., Gragoudas E. S. Arch Ophthalmol (Chicago) 1996; 114(2)186–192
  • , Physical and chemical stabilities of liposomes.
  • Bozkir A., Kocyigit S. Ankara Univ Eczacilik Fak Derg 1995; 24(1)42–52
  • , Physical enhancement of dermatologic drug delivery: Iontophoresis and phonophoresis
  • Kassan D. G., Lynch A. M., Stiller M. J. JAm Acad Dermatol 1996; 34(4)657–666
  • , Physicochemical characterization of the nisin-membram interaction with liposomes derived from Listeria monocytogenes.
  • Winkowski K., Ludescher R. D., Montville T. J. Appl Environ Microbiol 1996; 62(2)323–327
  • , Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion
  • Barzago M. M., Bortolotti A., Stellari F. F., Diomede L., Algeri M., Efrati S., Salmona M., Bonati M. J Pharmacol Exp Ther 1996; 277(1)79–86
  • , Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes.
  • Wasan E. K., Reimer D. L., Ballyand M. B. J Pharm Sci 1996; 85(4)427–433
  • , Plasmid–liposome transfer of the alpha 1 antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastaseinduced cell detachment and cytokine release.
  • Canonico A. E., Brigham K. L., Carmichael L. C., Plitman J. D., King G. A., Blackwell T. R., Christman J. W. Am J Respir Cell Mot Biol 1996; 14(4)348–355
  • , Plasmodium falciparum: The adherence of erythrocytes infected with human malaria can be mimicked using pfalhesin-coated microspheres
  • Guthrie N., McBird D. K., Crandall I., Sherman I. W. Cell Adhes Commun 1995; 3(5)407–417
  • , Plasmoviruses: Nonviral/viral vectors for gene therapy.
  • Noguiez H. P., Meur M. R., Salzmann J. L., Klatzmann D. Proc Nall Acad Sci USA 1996; 93(9)4175–4180
  • , Poly(ethylene glycol)—lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine
  • Holland J. W., Hui C., Cullis P. R., Madden T. D. Biochemistry 1996; 35(8)2618–2624
  • , Polyacrylamide microcapsules: Multipurpose drug carriers.
  • Sawant K. K., Murthy R. S. R. Indian J Hosp Pharm 1995; 32(3)96–97
  • , Preclinical and clinical activity of liposomal doxorubicin.
  • Boman N. L., Cullis P. R., Bally M. B., Mayer L. D. Drug Targeting Delivery 1995; 6: 85–103
  • , Preparation and lectin binding characteristics of N-stearyl lactobionamide liposomes.
  • Kim C.-K., Min K.-H., Oh Y.-K., Park K.-M., Kim K.-M. Int J Pharm 1996; 128(1,2)65–71
  • , Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method
  • Uchida T., Yoshida K., Goto S. J Microencapsulation 1996; 13(2)219–228
  • , Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: Drug carriers with an intrinsic anti-HIV activity.
  • Kamps J. A., Swart P. J., Morselt H. W., Pauwels R., De Bethune M. P., De Clercq E., Meijer D. K., Scherphof G. L. Biochim Biophys Acta 1996; 1278(2)183–190
  • , Preparation and evaluation of captopril microspheres by spherical crystallization.
  • Jayaswal S. B., Reddy T. S. R., Vijay K. M., Kumar G. V. Indian Drugs 1995; 32(9)454–457
  • , Preparation and evaluation of zidovudine-loaded sustained-release microspheres: 2. Optimization of multiple response variables.
  • Abu I. K., Garcia-Contreras L., Lu D. R. J Pharm Sci 1996; 85(6)572–576
  • , Preparation and characterisation of polyphosphazene. based controlled release systems for naproxen.
  • Caliceti P., Lora S., Marsilio F., Veronese F. M. Farmaco 1995; 50(12)867–874
  • , Preparation of biodegradable microspheres containing water-soluble drug β3-lactam antibiotic.
  • Kim J.-H., Kwon I.-C., Kim Y.-H., La S.-B., Soh Y., Jeong T. S.-Y. Arch Pharmacal Res 1996; 19(1)30–35
  • , Preparation of controlled releasing acrylic polymer micro spheres of acebutolol hydrochloride and those powder coated microspheres with sodium alginate in a polymeri spherical crystallization system.
  • Cui F., Kawashima Y., Takeuchi H., Niwa T., Hino T. Chem Pharm Bull 1996; 44(4)837–842
  • , Preparation and stability of interferon-α-containing lipo somes.
  • Karau C., Petszulat M., Schmidt P. C. Int J Pharn 1996; 128(1,2)89–98
  • , Preparation, characterization and in vitro drug release o1 poly-α-caprolactone and hydroxypropyl methyl cellulose phthalate ketoprofen loaded microspheres.
  • Guzman M., Molpeceres J., Garcia F., Aberturas M. R. J Microencapsulation 1996; 13(1)25–39
  • , Priming for virus-specific CD8+ but not CD4+ cytotoxic I lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
  • Babu J. S., Nair S., Kanda P., Rouse B. T. Vaccinm 1995; 13(17)1669–1676
  • , Prolongation of murine cardiac allograft survival by micro spheres containing TNFa and IL1-β neutralizing antibodies.
  • Gerber D.-A., Oettinger C. W., D'Souza M., Milton Larsen G. V. C. P., Pearson T. C. J Drug Targeting 1995; 3(4)311–315
  • , Protective immunity induced by liposome-supplemented influenza virus subunit antigen administered intranasally to mice.
  • De Haan A., van Scharrenburg G. J. M., Masihi Bender K. N. B. S., Small-Parter A., Jr, Wilschut J. Vaccine Res 1995; 4(4)207–216
  • , Quality control of 99mTc-labeled microspheres for studiei of the pulmonary blood circulation.
  • Potapova Z. M., Epstein N. B., Starovoytova Kharitonov L. P. Y. Y., Khleskov V. I., Kharlamov Skvortsov V. T. V. G. Pharm Pharmacol Lett 1995; 5(4)135–138
  • , Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transfer rin.
  • Cheng P.-W. Hum Gene Ther 1996; 7(3)275–282
  • , Receptor-mediated endocytosis of poly(acrylic acid)-conju. gated liposomes by macrophages.
  • Fujiwara M., Baldeschwieler J. D., Grubbs R. H. Biochim Biophys Acta 1996; 1278(1)59–67
  • , Receptor-mediated gene transfer to hepatic cells using asialofetuin-labeled liposomes.
  • Tsuchiya S., Hara T. Drug Delivery Syst 1996; 11(1)11–20
  • , Release profiles of recombinant human tumor necrosis factor from Ca2+-triggering liposome in vivo.
  • Yasui K., Fujioka H., Nakamura Y. Biol Pharm Bull 1996; 19(2)246–251
  • , Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
  • Zabner J., Ramsey B. W., Meeker D. P., Aitken M. L., Balfour R. P., Gibson R. L., Launspach J., Moscicki R. A., Richards S. M., Standaert T. A., Williams W. J., Wadsworth S. C., Smith A. E., Welsh M. J. J Clin Invest 1996; 97(6)1504–1511
  • , Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: A model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery
  • Kaga N., Katsuki Y., Obata M., Shibutani Y. Am J Obstet Gynecol 1996; 174(2)754–759
  • , Retrometabolic approaches to drug targeting.
  • Bodor N. NIDA Res Monogr 1995; 154: 1–27
  • , Reversible adsorption of endopectin-lyase to tailor-made core-shell microspheres prepared by dispersion polymerization. 3.
  • Dinnella C., Doria M., Laus M., Lanzarini G. Biotechnol Appl Biochem 1996; 23(2)133–140
  • , Serum-independent liposome uptake by mouse liver.
  • Liu E, Liu D. Biochim Biophys Acta 1996; 1278(1)5–11
  • , Single agent taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer.
  • Alberola V., Rosell R., Gonzalez-Larriba J. L., Molina F., Ayala F., Garcia-Conde J., Benito D., Perez J. M. Ann Oncol 1995; 6(l3)S49–S52
  • , Size dependent liposome degradation in blood: In vivo/in vitro correlation by kinetic modeling.
  • Harashima H., Hiraiwa T., Ochi Y., Kiwada H. J Drug Targeting 1995; 3(4)253–261
  • , Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.
  • Ferdous A. J., Ishida T., Shinohara M., Harashima H., Kiwada H. Biopharm Drug Dispos 1996; 17(2)145–154
  • , SOD-like activities of SOD and Cu(II) complexes in liposomes.
  • Liu Y., Li L.-T., Lu J.-S.-C.-S. J Chin Pharm Sci 1995; 4(4)177–180
  • , Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro.
  • Matsumoto Y., Imamura C., Ito T., Taniguchi C., Ueoka R. Biol Pharm Bull 1995; 18(10)1456–1458
  • , Specific targeting of phototoxic haptenated liposomes to a hapten-specific B cell lymphoma.
  • Avrilionis K., Boggs J. M. Cell Immunol 1996; 168(1)13–23
  • , Structural study of electrolysis-induced degradation of the growth hormone releasing peptide His-D-Trp-Ala-Trp-DPhe-Lys-NH2
  • Cheng H.-Y., Davis L. L., Huddleston M. J., Can S. A. Anal Chem 1995; 67(22)4053–4056
  • , Studies on the formulation and in vitro release of ophthalmic liposomes containing dexamethasone sodium phosphate.
  • Al-Muhammad J., Oezer A. Y., Hincal A. A. J Microencapsulation 1996; 13(2)123–130
  • , Studies on the mechanism of uptake of liposomes using an isolated perfused liver system.
  • Harashima H., Kiwada H. J Liposome Res 1996; 6(1)61–75
  • , Study on the lung targeting gelatin microspheres of streptomycin sulfate.
  • Zhang Z., Lu B., Shu G., Xie H., Yi Q., He Y., Wang J. Huaxi Yike Daxue Xuebao 1995; 26(2)167–171
  • , Study on the in vitro stability of polymerized liposomes.
  • Nishiya T., Jain B. Artif Cells, Blood Substitutes. Immobilization Biotechnol 1996; 24(1)43–50
  • , Surface modification of microspheres by plasma-graft polymerization.
  • Haraguchi T., Yamada K., Ide S., Hatanaka C., Goto M., Kumada K., Hatate Y., Kajiyama T. Kitakyushu Kogyo Koto Senmon Gakko Kenkyu Hokoku 1996; 29: 41–46
  • , Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
  • Fukuda M., Nishio K., Kanzawa F., Ogasawara H., Ishida T., Arioka H., Bojanowski K., Oka M., Saijo N. Cancer Res 1996; 56(4)789–793
  • , Synthesis of drug carrier: A copolymer microsphere of starch maleic acid ester.
  • Li L., Hou X., Sheng H. Beijing Yike Daxue Xuebao 1995; 27(5)393–395
  • , Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  • Magnani M., Casabianca A., Fraternale A., Brandi G., Gessani S., Williams R., Giovine M., Damonte G., De Flora A., Benatti U. Proc Natl Acad Sci USA 1996; 93(9)4403–4408
  • , Targeted cancer chemotherapy with arterial microcapsule chemoembolization: Review of 1013 patients.
  • Kato T., Sato K., Sasaki R., Kakinuma H., Moriyama M. Cancer Chemother Pharmacol 1996; 37(4)289–296
  • , Targeted delivery to the pilosebaceous unit via liposomes.
  • Lauer A. C., Ramachandran C., Lieb L. M., Niemiec S., Weiner N. D. Adv Drug Delivery Rev 1996; 18(3)311–324
  • , Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia.
  • Kakinuma K., Tanaka R., Takahashi H., Watanabe M., Nakagawa T., Kuroki M. J Neurosurg 1996; 84(2)180–184
  • , Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
  • Lussow A. R., Fanget L., Gao L., Buelow R., Pouletty P. Transplant Proc 1996; 28(2)571–572
  • , Targeting of cationic liposomes to skin-associated bacteria.
  • Sanderson N. M., Jones M. N. Pestic Sci 1996; 46(3)255–261
  • , Targeting p53 as a general tumor antigen.
  • Theobald M., Biggs J., Dittmer D., Levine A. J., Sherman L. A. Proc Nall Acad Sci USA 1995; 92(26)11993–11997
  • , Temperature-controlled release property of phospholipid vesicles bearing a thermo-sensitive polymer.
  • Hayashi H., Kono K., Takagishi T. Biochim Biophys Acta 1996; 1280(1)127–134
  • , The reversible aggregation–disaggregation and fusion of phosphatidylcholine liposomes with and without polyethylene glycol.
  • Ogihara T., Takamoto Y., Kumazawa H., Hayashi H. Seibutsu Butsuri Kagaku 1996; 40(1)7–12
  • , The delivery of aerosolized steroids from MDIs with nozzle extensions: Quantitative laboratory evaluation of a method to improve aerosol delivery to intubated patients
  • Hess D., Fisher D., Peterfreund R. A., Kacmarek R. M. Intensive Care Med 1995; 21(11)945–951
  • , The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation damage.
  • Heeremans J. L. M., Gerritsen H. R., Meusen S. P., Mijnheer F. W., Panday R. S. G., Prevost R., Kluft C., Crommelin D. J. A. J Drug Targeting 1995; 3(4)301–310
  • , The role of rat serum carboxylesterase in the activation of paclitaxel and camptothecin prodrugs.
  • Senter P. D., Marquardt H., Thomas B. A., Hammock B. D., Frank I. S., Svensson H. P. Cancer Res 1996; 56(7)1471–1474
  • , The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery.
  • Rabowsky J. H., Dukes A. J., Lee D. A., Leong K. W. Ophthalmology 1996; 103(5)800–807
  • , The application of in situ models for evaluation of new fluoride-containing systems.
  • Faller R. V. Adv Dent Res 1995; 9(3)290–303
  • , The effect of posture on nasal clearance of bioadhesive starch microspheres.
  • Ridley D., Perkins A. C., Washington N., Wilson C. G., Wastie M. L., O'Flynn P., Blattman A., Ponchel G., Duchene D. STP Pharma Sci 1995; 5(6)442–446
  • , The effect of liposomal dose on the intracellular fate of liposomes in rats in vivo.
  • Morioka Y., Harashima H., Yoshimua K., Kiwada H. Drug Delivery Syst 1996; 11(1)27–35
  • , The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage.
  • du Plessis J., Ramachandran C., Weiner N., Muller D. G. Int J Pharm 1996; 127(2)273–278
  • , The role of antibiotics in the treatment of periodontitis (Part 2—controlled drug delivery)
  • Needleman I. G., Pandya N. V., Smith S. R., Foyle D. M. Eur J Prosthodont Restor Dent 1995; 3(3)111–117
  • , The selective antitumor effect of immuno-chemo-liposomes on hamster osteosarcoma.
  • Takeuchi H. Tokyo Jikeikai Ika Daigaku Zasshi 1996; 111(1)49–56
  • , The use of 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia.
  • Ruble G., Wu C., Squire R. A., Ganswo O. A., Strand M. Int J Radiat Oncol Biol Phys 1996; 34(3)609–616
  • , The use of polymers in the construction of controlled-release devices.
  • Heller J. NIDA Res Monogr 1995; 154: 107–131
  • , The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.
  • Althaus I. W., Franks K. M., Langley K. B., Kezdy F. J., Peterson T., Buxser S. E., Decker D. E., Dolak L. A., Ulrich R. G., Reusser F. Experientia 1996; 52(4)329–335
  • , The role of liposomal delivery in cutaneous DNA repair.
  • Yarosh D., Klein J. Adv Drug Delivery Rev 1996; 18(3)325–333
  • , Therapeutic progress with topical liposome drugs for skin disease.
  • Schmid M. H., Korting H. C. Adv Drug Delivery Rev 1996; 18(3)335–342
  • , Thermodynamic approach to protein microencapsulation into poly(DL-lactide) by spray drying.
  • Gander B., Johansen P., Nam T.-H., Merkle H. P. Int J Pharm 1996; 129(1,2)51–61
  • , Thermodynamics of partitioning of nonsteroidal anti-inflammatory drugs in the n-octanol/buffer and liposome systems.
  • Betageri G. V., Nayernama A., Habib M. J. Int J Pharm Adv 1996; 1(3)310–319
  • , Toxicological aspects of the use of dextran microspheres and thermogelling ethyl hydroxyethyl cellulose (EHEC) as nasal drug delivery systems.
  • Pereswetoff-Morath L., Bjurstrom S., Khan R., Dahlin M., Edman P. Int J Pharm 1996; 128(1,2)9–21
  • , Transdermal modification of platelet function: An aspirin patch system results in marked suppression of platelet cyclooxygenase
  • McAdam B., Keimowitz R. M., Maher M., Fitzgerald D. J. J Pharmacol Exp Ther 1996; 277(2)559–564
  • , Transdermal delivery of zalcitabine: In vitro skin permeation study.
  • Kim D.-D., Chien Y.-W. AIDS 1995; 9(12)1331–1336
  • , Treating periodontal diseases with tetracycline-impregnated fibers: Data and controversies.
  • Greenstein G. Compend Contin Educ Dent 1995; 16(5)448–456
  • , Triamcinolone permeation from different liposome formulations through rat skin in vitro.
  • Yu H.-Y., Liao H.-M. Int J Pharm 1996; 127(1)1–7
  • , Triggerable plasmalogen liposomes: Improvement of system efficiency.
  • Thompson D. H., Gerasimov O. V., Wheeler J. J., Rui Y., Anderson V. C. Biochim Biophys Acta 1996; 1279(1)25–34
  • , Trypanocidal value of liposomal diminazene in experimental Trypanosoma brucei evansi infection in mice.
  • Yang Y., Ou Y., Ruan C., Cheng Y., Zhang F. Vet Parasitol 1996; 61(3–4)349–352
  • Sasaki M., Watanabe M., Kawakubo Y., Komiyama M., Kobayashi M., Fujita H. Photomed Photobiol 1995; 17: 103–104, Uptake of fluorescent oligonucleotides encapsulated in liposomes by cultured keratinocytes and their intracellular delivery process.
  • , Vector-mediated delivery of opioid peptides to the brain.
  • Bickel U., Pardridge W. M. NIDA Res Monogr 1995; 154: 28–46
  • , Vidarabine liposomes: Preliminary studies on the encapsulation of formulations.
  • Barbosa C. M., Da Cruz E. M. E. M. Rev Port Farm 1995; 45(4)161–173
  • , Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes.
  • Boman N. L., Tron V. A., Bally M. B., Cullis P. R. Cancer Chemother Pharmacol 1996; 37(4)351–355
  • , Virosomes: Cationic liposomes enhance retroviral transduction.
  • Hodgson C. P., Solaiman E. Nat Biotechnol 1996; 14(3)339–342
  • , XPS and TOF-SIMS microanalysis of a peptide/polymer drug delivery device.
  • John C. M., Odom R. W., Salvati L., Annapragada A., Fu-Lu M. Y. Anal Chem 1995; 67(21)3871–3878

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.